Feedback / Questions
N,N-dimethyltryptamine (AP-188) - Algernon Pharma
https://www.globenewswire.com/news-release/2025/02/11/3024039/0/en/Algernon-NeuroScience-Appoints-Globally-Recognized-DMT-Researcher-and-Clinician-Dr-S%C3%A1ndor-Nardai-as-Principal-Investigator-for-Planned-Phase-2a-DMT-Human-Stroke-Study.html
Feb 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next